Senior Vice President, Corporate Affairs, Editas Medicine
Tim is Senior Vice President, Corporate Affairs at Editas Medicine. He joined Editas Medicine in January 2016 and oversees global policy, early-stage commercial planning & market development, government affairs, human resources, and corporate communications.
Prior to joining Editas Medicine, Tim served as Senior Vice President of Public Affairs for Cubist Pharmaceuticals, the world’s largest developer of hospital-based antibiotics to combat superbugs, until the company was acquired by Merck in 2015. At Cubist, he oversaw global policy, government affairs, and communications.
Before joining Cubist, Tim spent several years at Biogen Idec, where he most recently served as Vice President of Public Affairs
Tim received his J.D. from the Columbus School of Law at the Catholic University of America and his B.A. in History and Philosophy from Boston College. He is a member of the Board of Directors of Life Sciences Cares.